Zhongzhi Pharmaceutical Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People's Republic of China. The company operates through two segments Pharmaceutical Manufacturing and Operation of Chain Pharmacies segments. It also provides Chinese patent medicines and decoction pieces under the Zeus, Liumian, and Caojinghua brand names. In addition, the company manufactures and sells food and Chinese herbs; offers detection and testing and property management. Further, the company engages in the wholesale of pharmaceutical products; and provision of traditional Chinese medicine service. Zhongzhi Pharmaceutical Holdings Limited was founded in 1993 and is headquartered in Zhongshan, the People's Republic of China. Zhongzhi Pharmaceutical Holdings Limited operates as a subsidiary of Crystal Talent Investment Group Limited.
Frequently asked questions
What sector does Zhongzhi Pharm Hldg Ltd (3737) operate in?
Zhongzhi Pharm Hldg Ltd belongs to the Consumer Staples sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Zhongzhi Pharm Hldg Ltd (3737) current stock price?
As of the latest data, Zhongzhi Pharm Hldg Ltd stock price is HK$0.71, with a previous close of HK$0.71.
What is Zhongzhi Pharm Hldg Ltd (3737) current market capitalization?
Zhongzhi Pharm Hldg Ltd market cap is approximately 599.06 million.
What is Zhongzhi Pharm Hldg Ltd (3737) EBITDA?
Zhongzhi Pharm Hldg Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 34.46 million.
Does Zhongzhi Pharm Hldg Ltd (3737) pay dividends?
No. Zhongzhi Pharm Hldg Ltd does not pay a dividend.
What is Zhongzhi Pharm Hldg Ltd (3737) beta (volatility) score?
Zhongzhi Pharm Hldg Ltd has a beta of 0.422, indicating lower volatility than the overall market.
